AEON Biopharma, Inc.AEON Biopharma, Inc.AEON Biopharma, Inc.

AEON Biopharma, Inc.

No trades
See on Supercharts
Market capitalization
‪247.14 M‬USD
−1.00USD
‪−36.63 M‬USD
‪11.09 M‬
Beta (1Y)
1.54

About AEON Biopharma, Inc.

CEO
Marc Forth
Headquarters
Irvine
Employees (FY)
10
Founded
2012
ISIN
US00791X1000
FIGI
BBG00Z17HDW3
AEON Biopharma, Inc. is a biopharmaceutical company. It engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AEON is 4.66 USD — it has decreased by 28.75% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange AEON Biopharma, Inc. stocks are traded under the ticker AEON.
AEON Biopharma, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
AEON stock is 41.56% volatile and has beta coefficient of 1.54. Check out the list of the most volatile stocks — is AEON Biopharma, Inc. there?
One year price forecast for AEON Biopharma, Inc. has a max estimate of 18.00 USD and a min estimate of 18.00 USD.
AEON earnings for the last quarter are 1.19 USD per share, whereas the estimation was −0.53 USD resulting in a 324.53% surprise. The estimated earnings for the next quarter are −0.40 USD per share. See more details about AEON Biopharma, Inc. earnings.
Yes, you can track AEON Biopharma, Inc. financials in yearly and quarterly reports right on TradingView.
AEON stock has fallen by 44.42% compared to the previous week, the month change is a 66.28% fall, over the last year AEON Biopharma, Inc. has showed a 54.27% decrease.
AEON net income for the last quarter is ‪−42.49 M‬ USD, while the quarter before that showed ‪22.63 M‬ USD of net income which accounts for −287.78% change. Track more AEON Biopharma, Inc. financial stats to get the full picture.
Today AEON Biopharma, Inc. has the market capitalization of ‪247.14 M‬, it has increased by 10.75% over the last week.
No, AEON doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AEON shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AEON Biopharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
AEON reached its all-time high on Mar 18, 2024 with the price of 17.17 USD, and its all-time low was 3.37 USD and was reached on Aug 23, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 10.00 employees. See our rating of the largest employees — is AEON Biopharma, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AEON Biopharma, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AEON Biopharma, Inc. stock shows the sell signal. See more of AEON Biopharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on AEON Biopharma, Inc. future price: according to them, AEON price has a max estimate of 18.00 USD and a min estimate of 18.00 USD. Read a more detailed AEON Biopharma, Inc. forecast: see what analysts think of AEON Biopharma, Inc. and suggest that you do with its stocks.